-+ 0.00%
-+ 0.00%
-+ 0.00%

DiaMedica Therapeutics Q3 EPS $(0.17), Inline

Benzinga·11/12/2025 21:31:10
Listen to the news
DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.17) per share which met the analyst consensus estimate. This is a 13.33 percent decrease over losses of $(0.15) per share from the same period last year.